These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19459875)

  • 21. Sorsby's pseudoinflammatory macula dystrophy--Sorsby's fundus dystrophies.
    Capon MR; Polkinghorne PJ; Fitzke FW; Bird AC
    Eye (Lond); 1988; 2 ( Pt 1)():114-22. PubMed ID: 2457521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fundus Autofluorescence Changes After Ranibizumab Treatment for Subfoveal Choroidal Neovascularization Secondary to Pathologic Myopia.
    Parodi MB; Iacono P; Sacconi R; Iuliano L; Bandello F
    Am J Ophthalmol; 2015 Aug; 160(2):322-327.e2. PubMed ID: 25935099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase-3 induce apoptosis of retinal pigment epithelial and MCF-7 cells.
    Majid MA; Smith VA; Easty DL; Baker AH; Newby AC
    FEBS Lett; 2002 Oct; 529(2-3):281-5. PubMed ID: 12372614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodal fundus imaging of pseudoxanthoma elasticum.
    Zweifel SA; Imamura Y; Freund KB; Spaide RF
    Retina; 2011 Mar; 31(3):482-91. PubMed ID: 20966826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antiangiogenic therapy in Sorsby's fundus dystrophy without a mutation in the TIMP-3 gene].
    Copete-Piqueras S; Cava-Valenciano C; Flores-Moreno I; Moreno-Valladares A; Bautista Ruescas V
    Arch Soc Esp Oftalmol; 2013 Jun; 88(6):240-3. PubMed ID: 23726310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.
    Felbor U; Stöhr H; Amann T; Schönherr U; Apfelstedt-Sylla E; Weber BH
    J Med Genet; 1996 Mar; 33(3):233-6. PubMed ID: 8728699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic and morphological differences between choroidal excavations.
    Kumano Y; Nagai H; Enaida H; Ueno A; Matsui T
    Optom Vis Sci; 2013 Apr; 90(4):e110-8. PubMed ID: 23435223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue inhibitor of metalloproteinases-3 and Sorsby fundus dystrophy.
    Qi JH; Ebrahem Q; Anand-Apte B
    Adv Exp Med Biol; 2003; 533():97-105. PubMed ID: 15180253
    [No Abstract]   [Full Text] [Related]  

  • 29. Eales disease associated with serpiginous choroiditis.
    Fung AT; Nicolò M; Yzer S; Traverso CE; Yannuzzi LA
    Arch Ophthalmol; 2012 Nov; 130(11):1484-6. PubMed ID: 23143459
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute posterior multifocal placoid pigment epitheliopathy (APMPPE).
    Opremcak EM
    Insight; 2013; 38(1):21. PubMed ID: 23505795
    [No Abstract]   [Full Text] [Related]  

  • 31. Decompensation of the retinal pigment epithelium and occult choroidal neovascularization: indications for treatment.
    Morse PH
    Ann Ophthalmol; 1987 Jul; 19(7):276-9. PubMed ID: 2443053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fundus autofluorescence and spectral optical coherence tomography findings in a case with acute posterior multifocal placoid pigment epitheliopathy.
    Batioglu F; Ozmert E; Kurt R
    Ann Ophthalmol (Skokie); 2008; 40(3-4):185-9. PubMed ID: 19230362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choroidal perfusion abnormality with age-related Bruch's membrane change.
    Pauleikhoff D; Chen JC; Chisholm IH; Bird AC
    Am J Ophthalmol; 1990 Feb; 109(2):211-7. PubMed ID: 2301534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heredity of the choroidal dystrophies.
    François J
    Adv Ophthalmol; 1978; 35():1-25. PubMed ID: 343550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fundus autofluorescence findings of choroidal osteoma.
    Sisk RA; Riemann CD; Petersen MR; Foster RE; Miller DM; Murray TG; Augsburger JJ
    Retina; 2013 Jan; 33(1):97-104. PubMed ID: 22718153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.
    Chong NH; Alexander RA; Gin T; Bird AC; Luthert PJ
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):898-902. PubMed ID: 10711711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical course and treatment outcomes of Sorsby fundus dystrophy.
    Sivaprasad S; Webster AR; Egan CA; Bird AC; Tufail A
    Am J Ophthalmol; 2008 Aug; 146(2):228-234. PubMed ID: 18501328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sorsby's pseudo-inflammatory macular dystrophy: laser treatment].
    Segato T; Piermarocchi S; Midena E; Leperdi M
    J Fr Ophtalmol; 1989; 12(12):863-8. PubMed ID: 2640217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comment on "fundus autofluorescence and multiple evanescent white dot syndrome".
    Sisk RA; Wykoff CC; Albini TA
    Retina; 2009 Oct; 29(9):1377-8; author reply 1378-9. PubMed ID: 19934830
    [No Abstract]   [Full Text] [Related]  

  • 40. Autosomal dominant crystalline dystrophy.
    Richards BW; Brodstein DE; Nussbaum JJ; Ferencz JR; Maeda K; Weiss L
    Ophthalmology; 1991 May; 98(5):658-65. PubMed ID: 2062498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.